NASH com­pa­ny Madri­gal names for­mer Sanofi ex­ec Bill Si­bold as new CEO

Madri­gal Phar­ma­ceu­ti­cals has ap­point­ed ex-Sanofi ex­ec­u­tive Bill Si­bold as its new CEO, suc­ceed­ing Paul Fried­man, who will con­tin­ue to serve on the biotech’s board of di­rec­tors.

Si­bold was pre­vi­ous­ly ex­ec­u­tive vice pres­i­dent of spe­cial­ty care at Sanofi, where he over­saw 10,000 peo­ple work­ing across five spe­cial­ty ther­a­peu­tic ar­eas. Un­der his lead­er­ship, the spe­cial­ty care unit sus­tained dou­ble-dig­it growth and launched its block­buster an­ti-in­flam­ma­to­ry der­ma­tol­ogy prod­uct Dupix­ent.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER